‘Unprecedented’ demand for Eli Lilly’s Zepbound sparks US supply constraints zbecker Fri, 03/29/2024 – 13:15 More: 'Unprecedented' demand for Eli Lilly's Zepbound sparks US supply constraints Source: fierce
read moreTeva, following Hikma complaint, alleges Amarin ‘locked up’ Vascepa ingredient to block generics fkansteiner Fri, 03/29/2024 – 11:47 More: Teva, following Hikma complaint, alleges Amarin 'locked up' Vascepa ingredient to block generics Source: fierce
read moreJ&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti kdunleavy Fri, 03/29/2024 – 11:04 More: J&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti Source: fierce
read morePrecigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis apark Fri, 03/29/2024 – 10:48 More: Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis Source: fierce
read moreAfter Amgen’s stumble, BMS touts KRAS confirmatory trial win for newly bought Krazati aliu Fri, 03/29/2024 – 10:18 More: After Amgen's stumble, BMS touts KRAS confirmatory trial win for newly bought Krazati Source: fierce
read moreGenmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly fkansteiner Thu, 03/28/2024 – 16:02 More: Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals